Pacific Edge Ltd

ow will the integration of digital platforms like the Pacific Edge customer portal enhance clinician and patient engagement, and what measurable outcomes are expected?

With a shift in focus to profitable territories and a reduction in sales and marketing expenses (down 42.5% compared to 1H 24), how is the company balancing cost reduction with efforts to expand market presence?

How is the company mitigating risks associated with a potential non-coverage determination by Novitas for the Cxbladder tests under the proposed LCD DL39365

What steps is Pacific Edge taking to address the 16.3% decline in operating revenue compared to 1H 24, and how do they plan to counteract Medicare-related uncertainties impacting test volumes?